Catalyst Capital Advisors’s Novavax NVAX Stock Holding History

Catalyst Capital Advisors’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-42,300	Closed	-$5.02M	–	508
2014 Q4	$5.02M	Buy	42,300 +500	+1%	+$52.3K	0.59%	55
2014 Q3	$3.49M	Buy	41,800 +17,000	+69%	+$1.54M	0.45%	69
2014 Q2	$2.29M	Buy	24,800 +21,050	+561%	+$1.85M	0.37%	86
2014 Q1	$340K	Buy	+3,750	New	+$419K	0.08%	242
2013 Q4	–	Sell	-20,095	Closed	-$1.27M	–	294
2013 Q3	$1.27M	Buy	+20,095	New	+$1.13M	0.69%	34

Other funds holding NVAX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Catalyst Capital Advisors's NVAX Position: Q1 2015 in Review

Catalyst Capital Advisors sold out of Novavax (NVAX) in Q1 2015, closing a stake of 42,300 shares — an estimated $5.02M sold.

Catalyst Capital Advisors first reported a position in NVAX in Q3 2013 and held it in 5 quarters. The position peaked at $5.02M in Q4 2014. 167 funds tracked by Wall St. Rank hold NVAX as of Q1 2015.

Catalyst Capital Advisors reported no remaining Novavax position as of Q1 2015 after selling out during the quarter.
Catalyst Capital Advisors sold 42,300 Novavax shares in Q1 2015, an estimated $5.02M.
Catalyst Capital Advisors first reported a position in Novavax in Q3 2013 and held it in 5 quarters.
Catalyst Capital Advisors's Novavax position peaked at $5.02M in Q4 2014.
167 funds tracked by Wall St. Rank held Novavax as of Q1 2015.

Based on Catalyst Capital Advisors's 13F filing for Q1 2015, filed 15 May 2015.